Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

The S&P 500 Index ($SPX ) (SPY ) today is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off on some...

Barchart

Stocks Move Higher on Strength in Chip Stocks and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.11%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off as chip...

Barchart

Moderna MRNA Mpox Vaccine Shows Promise In Animal Study

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease symptoms and duration, according to an animal study published in the journal Cell on Wednesday.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.

Fortune

When is Canada launching new Covid vaccines targeting KP.2 variant? All you want to know

Close on the heels of US approving vaccines to fight KP.2 variant of Omicron, Health Canada has said they are reviewing updated vaccines that target the strain currently in circulation. The health regulator has said the review process will be completed by early autumn, post which the vaccines will be…

The Times of India

A new Covid vaccine is available. Here’s why some people might not want it right away

Updated Covid vaccines were approved by the FDA earlier this month

The Independent UK

FDA Approves Updated Covid-19 Vaccines From Moderna And Pfizer

FDA approves updated Covid-19 vaccines from Moderna and Pfizer/BioNTech to enhance protection against current variants and combat rising cases.

Top News

FDA greenlights updated COVID shots, prepares for fall rollout - Roll Call

The FDA approved updated COVID-19 vaccines for the 2024-25 season, preparing for an expected spike in cases this fall and winter.

Roll Call

Infectious diseases spike when kids return to school − here’s what you can do about it

Ready or not, back-to-school season is here, and kids will be bringing home more than homework. They’ll be carrying germs, too.

The Conversation

Top recruiters and CHROs from Moderna, Hilton, PwC say these are the 6 ways to stand out in a cooling job market

Job seekers need to hone a personal brand, upskill themselves, and stay resilient.

Fortune

Moderna's Quarterly Earnings Preview: What You Need to Know

Moderna is expected to release its fiscal second-quarter earnings next month, and analysts project a narrower loss.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

Salon

Bird flu vaccines in development

As part of the Biden admin's pandemic preparedness strategy, Moderna will develop an mRNA vaccine for H5N1

Barchart

Is Moderna Stock Outperforming the S&P 500?

Moderna recently outperformed the S&P 500, and Wall Street analysts are moderately optimistic about the stock’s prospects.

The Conversation

Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit public health

Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza.

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

2-in-1 shot for flu and COVID shows promise in advanced trial

The pharmaceutical company Moderna announced promising results from the ongoing trial of its new vaccine, mRNA-1083.

The Guardian - UK

Moderna combi flu and Covid jab gives better protection, study finds

Clinical trials show two-in-one jab may bring about higher immune responses than separate inoculations

The Independent UK

Combined Covid and flu vaccine could be approved for use on NHS by next year

New vaccine could cut need for separate Covid and flu jabs

The Independent UK

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

Government advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall

The Guardian - UK

‘Extremely impressive’: melanoma jab trial results excite doctors

Vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinician

Salon

Bird flu vaccines face a problem: eggs

Fertilized hen eggs are still the main ingredient in making vaccines that may protect us against H5N1

The Independent UK

Scientists are testing mRNA vaccines to protect cows and people against bird flu

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to the shots deployed during the COVID-19 pandemic

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.